Hsp90 is essential in the filarial nematode Brugia pahangi

被引:49
作者
Devaney, E
O'Neill, K
Harnett, W
Whitesell, L
Kinnaird, JH
机构
[1] Univ Glasgow, Inst Comparat Med, Div Infect & Immun, Parasitol Grp, Glasgow G61 1QH, Lanark, Scotland
[2] Univ Strathclyde, Dept Immunol, Glasgow G4 0NR, Lanark, Scotland
[3] Univ Arizona, Steele Mem Childrens Res Ctr, Tucson, AZ 85724 USA
基金
英国惠康基金;
关键词
Hsp90; filarial worms; geldanamycin; macrofilaricide;
D O I
10.1016/j.ijpara.2005.01.007
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The development of a compound with activity against filarial nematodes (a 'macrofilaricide') has been a long-standing goal of the World Health Organization. However, adult filariae have proved remarkably difficult to kill. To some extent this reflects a lack of understanding of key pathways and processes in filarial nematodes that may be suitable targets for chemotherapy. In this paper we show that geldanamycin (GA), a specific inhibitor of the activity of the heat shock protein 90 (Hsp90) family, kills adult worms and microfilariae (Mf) of Brugia pahangi at nanomolar concentrations. In addition, release of Mf from adult worms is inhibited within 24 It of exposure to GA and is not recoverable, demonstrating that GA effectively sterilises the worm. Similar results were obtained with a second filarial worm Acanthocheilonema viteae. In contrast GA has no effect on the free-living nematode Caenorhabditis elegans despite a high degree of conservation between the nematode Hsp90 sequences. In keeping with these findings, Brugia Hsp90 binds GA in a solid phase pull-down assay while the binding of C. elegans Hsp90 to immobilised GA is undetectable. In other eukaryotes, GA is known to bind in the N-terminal ATP pocket of Hsp90, disrupting its interactions with client proteins which are then targeted for degradation via the proteasome pathway. Thus, Hsp90 or some of its client proteins may provide novel targets for the chemotherapy of filarial infection. (C) 2005 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:627 / 636
页数:10
相关论文
共 51 条
[1]   A ROLE FOR HSP90 IN CELL-CYCLE CONTROL - WEE1 TYROSINE KINASE-ACTIVITY REQUIRES INTERACTION WITH HSP90 [J].
ALIGUE, R ;
AKHAVANNIAK, H ;
RUSSELL, P .
EMBO JOURNAL, 1994, 13 (24) :6099-6106
[2]  
Bagatell R, 2004, MOL CANCER THER, V3, P1021
[3]  
Bagatell R, 2001, CLIN CANCER RES, V7, P2076
[4]   Role of the myosin assembly protein UNC-45 as a molecular chaperone for myosin [J].
Barral, JM ;
Hutagalung, AH ;
Brinker, A ;
Hartl, FU ;
Epstein, HF .
SCIENCE, 2002, 295 (5555) :669-671
[5]  
Birnby DA, 2000, GENETICS, V155, P85
[6]   Development of Purine-Scaffold Small Molecule Inhibitors of Hsp90 [J].
Chiosis, Gabriela ;
Lucas, Brian ;
Huezo, Henri ;
Solit, David ;
Basso, Andrea ;
Rosen, Neal .
CURRENT CANCER DRUG TARGETS, 2003, 3 (05) :371-376
[7]   Brugia pahangi and Wolbachia:: the kinetics of bacteria elimination, worm viability, and host responses following tetracycline treatment [J].
Chrigwin, SR ;
Nowling, JM ;
Coleman, SU ;
Klei, TR .
EXPERIMENTAL PARASITOLOGY, 2003, 103 (1-2) :16-26
[8]   The 90-kDa molecular chaperone family:: Structure, function, and clinical applications.: A comprehensive review [J].
Csermely, P ;
Schnaider, T ;
Soti, C ;
Prohászka, Z ;
Nardai, G .
PHARMACOLOGY & THERAPEUTICS, 1998, 79 (02) :129-168
[9]  
David CL, 2003, CELL STRESS CHAPERON, V8, P93, DOI 10.1379/1466-1268(2003)8<93:EOAUDH>2.0.CO
[10]  
2